How Can the High-Performing Specialty Pharmacy Association Benefit Pharma Manufacturers?



 
Truitt: These pharmacies produce top level outcomes, great results in persistence and compliance, and they also invest heavily in information technology to facilitate care and to coordinate reporting. So the concept is to work together to leverage purchasing, reporting, access to limited distribution drugs, and programs around that, and to provide payers with access to a large, high quality, specialty pharmacy network with broad access to drugs.

Most Popular

Related Articles

The US Preventive Services Task Force recommends against routine screening for prostate cancer in men 70 years of age and older.
In this clip, Gordon Vanscoy, PharmD, MBA, CEO of PANTHERx Specialty Pharmacy, explains how orphan drugs are making an impact on patients in the era of precision medicine.
In this video, Gordon Vanscoy, PharmD, MBA, CEO of PANTHERx, describes the methods of patient support used by PantheRx throughout treatment to provide optimal care.
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$